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Abstract
Background: Sensitive detection of low-frequency single nucleotide variants carries great significance in many
applications. In cancer genetics research, tumor biopsies are a mixture of normal and tumor cells from various
subpopulations due to tumor heterogeneity. Thus the frequencies of somatic variants from a subpopulation
tend to be low. Liquid biopsies, which monitor circulating tumor DNA in blood to detect metastatic potential,
also face the challenge of detecting low-frequency variants due to the small percentage of the circulating tumor DNA
in blood. Moreover, in population genetics research, although pooled sequencing of a large number of individuals is
cost-effective, pooling dilutes the signals of variants from any individual. Detection of low frequency variants is difficult
and can be cofounded by sequencing artifacts. Existing methods are limited in sensitivity and mainly focus
on frequencies around 2 % to 5 %; most fail to consider differential sequencing artifacts.
Results: We aimed to push down the frequency detection limit close to the position specific sequencing error rates
by modeling the observed erroneous read counts with respect to genomic sequence contexts. 4 distributions suitable
for count data modeling (using generalized linear models) were extensively characterized in terms of their
goodness-of-fit as well as the performances on real sequencing data benchmarks, which were specifically designed for
testing detection of low-frequency variants; two sequencing technologies with significantly different chemistry
mechanisms were used to explore systematic errors. We found the zero-inflated negative binomial distribution
generalized linear mode is superior to the other models tested, and the advantage is most evident at 0.5 %
to 1 % range. This method is also generalizable to different sequencing technologies. Under standard sequencing
protocols and depth given in the testing benchmarks, 95.3 % recall and 79.9 % precision for Ion Proton data, 95.6 %
recall and 97.0 % precision for Illumina MiSeq data were achieved for SNVs with frequency > = 1 %, while the detection
limit is around 0.5 %.
Conclusions: Our method enables sensitive detection of low-frequency single nucleotide variants across different
sequencing platforms and will facilitate research and clinical applications such as pooled sequencing, cancer early
detection, prognostic assessment, metastatic monitoring, and relapses or acquired resistance identification.
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Background
In 2005, the first next-generation sequencing (NGS) tech-
nology was released by 454 Life Sciences (now Roche) [1].
Within the past ten years, different sequencing technologies
and platforms, including Illumina, SOLiD, Ion Torrent,
Complete Genomics, were released to the public. The
much faster sequencing speed, high-throughput capacity
and now up to several hundred bases read length, together
with a greatly reduced cost, revolutionized the scope and
efficiency of biomedical related field researches [2]. Paired
with the increasingly diverse range of biological application
of NGS technologies, numerous computational and inform-
atics tools, frameworks and pipelines emerged to enable re-
searchers to harness the power of NGS technologies.
Statistical models suitable for count data modeling gained
much attention in NGS data analysis due to the discrete
count nature of the data generated by NGS sequencers.
Such models were broadly applied in DNA sequencing
(DNA-Seq) based variants identification such as samtools
[3], VarScan2 [4], and SNVMix [5]. For DNA sequencing
based single nucleotide variant (SNV) identification, emer-
ging new applications bring challenges to refine the statis-
tical modeling methods and pushing the limit of NGS
technologies.
In cancer genetics research, low frequency tumor somatic
SNV identification is crucial due to the inevitable normal
tissue contamination [6, 7] and the highly heterogeneous,
constantly evolving nature of tumors [8]. Accurate and sen-
sitive identification of low frequency SNVs also carries clin-
ical significance, since it enables the early diagnosis, cancer
progression monitor and relapse identification. The recent
discovery of circulating tumor DNA (ctDNA) also gained
much attention. Contrast to traditional tumor biopsies,
which is invasive and can only offer a snapshot of the
tumor genetics landscape at certain checkpoints, ctDNA
based ‘liquid biopsy’ [9] is non-invasive and can be done re-
peatedly for close monitoring of early sign of relapse or me-
tastasis. However, ctDNA only takes a small percentage of
all blood sample DNA, a previous research [10] reported
for some advanced cancers, ctDNA is about 1 ~ 10 % of
blood DNA.
The difficulty for low-frequency SNV identification using
NGS technologies is due to the relatively high sequencing
artifacts or error rates, which is around 0.1 ~ 1 % for most
platforms. Further, such error rates differ significantly under
various genome contexts. For example, Illumina sequencing
data are prone to have mismatches while Ion Torren and
Ion Proton data contain more homopolymer related indels
and consequently, mismatches near homopolymer loci
[11–13]. For somatic SNV identification paired tumor-
normal design, some existing methods derive the sequencing
error probability from base qualities followed by error likeli-
hood ratio test of tumor and normal sample at the same lo-
cation, for example in Mutect [7], Strelka [14]. While
VarScan2 applies a Fisher’s exact test on the paired samples,
treating non-reference read counts from the normal sample
as background error rate. The former failed to consider dif-
ferential error rates for substitution types while the latter
only utilized information in one location thus the back-
ground error rate estimation is off. For one sample low-
frequency SNV calling, UDT-Seq [15] tabulated the error
rate based on substitution types, strand and location on the
read to derive an empirical background error rate, then use
binomial model to distinguish signal from error, and the can-
didate SNVs are further refined by 7 filters. This method is
context-aware but also ad-hoc, thus the ability to adapt to
different sequencing technologies is limited. A brief summary
of the tools mentioned above is included in Additional file 1.
By analyzing previous efforts, our group proposed a
framework (Yangyang Hao XX, Li L, Nakshatri H,
Edenberg HJ, Liu Y. RareVar: A Framework for Detecting
Low Frequency Single Nucleotide Variants, submitted) to
first generated position specific error model (PSEM) using
genome sequence contexts for candidate SNV identifica-
tion and then apply a machine-learning model to refine
the candidates. Testing on an Ion Proton benchmark data-
set, our framework outperforms existing methods, espe-
cially at 0.5 % to 3 % frequencies. However, the potential
to improve PSEM performances on SNVs with close to se-
quencing error rates by implementing more sophisticated
statistical modeling and the generalizability and adaptive-
ness of PSEM remain untested. In this research, we ex-
plored what distributions fit the DNA-Seq data error rates
modeling as well as the possibility of improved position
specific error rate prediction for higher precision and
recall on SNVs down to 0.5 % frequency. Further, we
evaluated how different sequencing technologies affect the
behavior of PSEM and the generalizability and adaptive-
ness of the PSEM framework.
Results
In the Result section, we first briefly summarized the
benchmark datasets used for PSEM. Then we compared
the testing benchmark dataset from Ion Proton with Illu-
mina MiSeq sequencing data in terms of allele frequency
composition and depth distribution. Utilizing count data
visualization plots and tabulation, we selected the candi-
date distributions that may fit the data. Since the Ion Pro-
ton dataset contains 3 times of the number of benchmark
SNVs from Illumina MiSeq and also is enriched with
SNVs of ≤ 1 % allele frequency, we mainly focused on Ion
Proton data set for model development and evaluation.
To test the generalizability of the PSEM, we further
trained and evaluated it on Illumina MiSeq dataset.
Benchmarks overview and comparison
Two sets of designed benchmarks targeting low-
frequency SNVs from both Ion Proton and Illumina
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MiSeq [15] sequencing technologies were included. The
details of these 2 datasets are described in Methods sec-
tion and Additional files 2 and 3. Briefly, the Ion Proton
training benchmark is the sequencing data from a single
individual with known genotypes, while the test bench-
mark was designed to mimic the paired normal-tumor de-
sign for somatic SNVs identification applications. The
Illumina MiSeq benchmark data were generated by
mixing 4 individuals at 4 different percentages and then
permuted the mixing percentage assignment 4 times to
generate 4 calibration datasets – CAL_A, CAL_B, CAL_C
and CAL_D. Since the 4 calibration data sets were gener-
ated with the same procedures, without loss of generality,
we used CAL_A as training benchmark and treated the
others as testing benchmark.
Comparing the two testing benchmarks, Ion Proton
contains a total of 1557 somatic SNVs while Illumina
MiSeq contains 514 SNV – mixed allele frequency pairs,
with 175 unique SNVs. More importantly, Ion Proton
benchmark was designed to comprehensively characterize
the SNV caller performance on close to sequencing error
allele frequencies, thus it is enriched with SNVs of < = 3 %
allele frequencies, with 0.5 % as the lowest targeted fre-
quency. Plotting the cumulative percentages of SNV num-
bers at different allele frequencies (Fig. 1) from the two
test benchmarks, it is clear the major components of Ion
Proton benchmark SNV allele frequencies are at 0.5 %,
1 %, 2 % to 5 %, followed by continuous frequencies until
46 %, the maximum somatic SNV frequency designed in
the dataset. Whereas MiSeq data set includes roughly
equal percentages of SNVs at 4 discrete allele fre-
quency levels.
Except for allele frequency composition, sequencing
depth is also a crucial factor affecting the performances
of the SNV callers, especially at the low-frequency
ranges. The average depth for Ion Proton sequencing
testing benchmark is about 4000x and about 1500x for
MiSeq. In addition, despite the amplicon-based capture
assay was applied on benchmark datasets from both
technologies, the evenness of the depth across the tar-
geted regions is different. When comparing the depth on
known testing benchmark SNV loci of two technologies
(Fig. 2), the depth distribution for Ion Proton is skewed
while the distribution profile for Illumina MiSeq data
displays a bell shape. Further, the average depth at SNV
loci from both benchmarks are around 3000x, despite
the much higher overall depth for Ion Proton. Thus, we
speculate lowered recall for some Ion Proton benchmark
SNVs, particularly for the ≤ 1 % ones, the identifiable
power of which are more sensitive to the depth and read
count number sampling variances.
Candidate distributions selection
To model error rate based on count data, 3 most com-
mon distribution choices are binomial, Poisson and
negative binomial (NB) distributions. We applied a
graphical exploratory plot – distplot [16–18] on the
model response – number of reads containing non-
reference bases – to get visual intuition about the overall
fit of response data on different distributions. Intuitively,
if an assumed distribution fits the data well, the data
points should follow a straight line determined by the
distribution metameters. As shown in Fig. 3, the obvious
curve for binomial distribution plot suggests binomial
distribution is not appropriate. The Poisson and NB
plots show better agreement with the straight line al-
though both curves deviate more from the straight line
when the x-axis approaches 0. Tabulating the percent-
ages of zero in the model responses show for Ion Proton
training dataset, 85 % is 0 while 80 % for MiSeq training
data. Thus zero-inflated models should be considered. In
the modeling step, we included Poisson, NB and their
zero-inflated counterparts (zero-inflated Poisson [19] or
ZIP and zero-inflated negative binomial [20] or ZINB) as
the candidate distributions under generalized linear
model (GLM) framework.
Comparing the goodness-of-fit of different distributions
9 genomic sequence context covariates, totaling 24 de-
grees of freedom, were included in the GLM models
(Methods and Additional file 4). Since ZIP and ZINB
GLM require covariates for both the ‘zero’ and ‘count’
parts, the same covariates were provided for both,
Fig. 1 Allele frequency composition of Ion Proton and Illumina
MiSeq testing benchmark SNVs
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Fig. 2 SNV loci depth distribution by allele frequency for Ion Proton and Illumina MiSeq. The dashed lines show the 3000x depth
Fig. 3 Distplot on binomial, Poisson and negative binomial distributions. The y-axis is the distribution metameter calculated by the method
distplot used. The open points show the observed count metameters; the filled points show the confidence interval centers and the dashed
lines show the confidence intervals for each point. 95 % confidence interval is used
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resulting in doubled degrees of freedom of those in-
cluded in Poisson and NB GLM.
To compare the goodness-of-fit of models based on dif-
ferent distributions, we used Vuong’s non-nested hypoth-
esis test [21]. BIC-corrected Vuong z-statistic was used to
impose stronger penalty on additional parameters. The
pairwise comparison results are summarized in Table 1.
Poisson distribution GLM is treated as the reference dis-
tribution to compare to, given its simple configuration. As
expected, NB GLM is superior to Poisson GLM, since NB
models dispersion of the data, and this is also supported
by dispersion test [22] (z = 68.5881, p value < 2.2e-16). The
necessity of modeling zero-inflation is supported by the
Vuong’s test comparing ZIP with Poisson GLM. When
comparing ZIP with NB, NB fits the data better. However,
it is worth noting the evidence of superiority – the abso-
lute value of BIC-corrected Vuong z-statistic – is much
smaller than the other tests. The merit of considering both
dispersion and zero-inflation is further emphasized by the
comparisons of ZIP with ZINB and NB with ZINB. In
conclusion, based on Vuong’s test, for Ion Proton sequen-
cing dataset, the most appropriate distribution is ZINB,
followed by NB, ZIP and Poisson.
Performance evaluation on Ion Proton testing benchmark
We first evaluated the overall precision and recall values
of all models on the test benchmark. From Table 2, it is
observed the Poisson GLM achieves the highest recall
while ZINB GLM has the highest precision. F1 score, the
harmonic mean of precision and recall, is used to evaluate
the overall performance. The conclusion from F1 score is
consistent with that of Vuong’s test, with ZINB performs
the best, followed by NB, ZIP and Poisson GLM. However,
the precision values listed in Table 2 are lower than the
ones reported previously [7, 14, 15]. There are 2 major
reasons: 1. the Ion Proton test benchmark dataset is de-
signed to enrich with low-frequency SNVs, with 68.9 % of
all SNVs of allele frequency < = 3 %, in which 17.3 % at
0.5 % frequency and 19.8 % at 1 % frequency, whereas the
majority of previous studies focused on SNVs of > = 5 %
allele frequency; 2. one popular paradigm of SNV calling
is a two-step procedure, first generating SNV candidates
and then applying multiple sequencing quality filters to
refine the SNV call. The PSEM aims to efficiently re-
cover high quality SNV candidates to facilitate the fil-
tering step, thus it is only fair to compare the
performance of PSEM with other candidate generating
methods. The result from VarScan2 before applying se-
quencing quality filters was included in Table 2. It is
evident that except for Poisson GLM, the other
methods outperformed VarScan2 in both recall and
precision. Therefore, choosing appropriate statistical
modeling method enables us to recover more true
SNVs without any loss of precision in candidate gener-
ating step.
Next, for all distributions, we explored the perform-
ance profiles on different allele frequencies. As shown in
Fig. 4, the well-separated F1 score levels clearly show
that SNVs of lower allele frequencies are more difficult
to identify, no matter what distributions were used. In
addition, the significant separation of 0.5 % from the
other allele frequencies indicate the detection limit is
around 0.5 % under current sequencing platform and
depth. Meanwhile, the power of appropriate modeling is
evident when comparing the performances of all distri-
butions on SNVs of 0.5 % allele frequency. Relative to
Poisson GLM, considering either zero-inflation or dis-
persion boosted the F1 score by about 0.2 at 0.5 %, while
considering both by ZINB further increased F1 score by
about 0.1. Interestingly, compared with the second best
model – NB GLM, both precision and recall increased
in ZINB GLM, which pinpoints the necessity of model-
ing zero-inflation to derive more accurate error rates es-
timation. Furthermore, for SNVs with allele frequency
greater than 1 %, the average recall is 97.5 % with 82.3 %
average precision for ZINB GLM. To summarize, the
performance evaluation results on low-frequency SNV
identification also support the conclusion from Vuong’s
non-nested test, with ZINB being the most appropriate
model. Further, the necessity of modeling both disper-
sion and zero-inflation is exemplified by the much-
elevated performance at close to sequencing error rate
allele frequency, which is important for pushing down
the detection limit of low-frequency SNV callers.
Application of ZINB PSEM on Illumina MiSeq data
To evaluate the generalizability and adaptiveness of the
GLM based PSEM, the same modeling strategies were
applied to the Illumina MiSeq sequencing data sets. The
Table 1 Vuong’s non-nested tests on 4 distributions applied to
Ion Proton training data
Model 1 Model 2 Vuong z-statistic
BIC-corrected
Hypothesis P value
Poisson NB −122.67 model2 >model1 <2.22e-16
Poisson ZIP −143.73 model2 >model1 <2.22e-16
NB ZIP 36.81 model1 >model2 <2.22e-16
ZIP ZINB −92.16 model2 >model1 <2.22e-16
NB ZINB −119.51 model2 >model1 <2.22e-16
Table 2 Overall performance comparison for Ion Proton testing
benchmark
Poisson NB ZIP ZINB VarScan2
Recall 0.98 0.89 0.95 0.90 0.83
Precision 0.25 0.62 0.54 0.71 0.53
F1 Score 0.40 0.73 0.69 0.79 0.65
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same genomic sequence context features from Ion Pro-
ton modeling were applied to the Illumina MiSeq
CAL_A dataset. Similar to the analysis on Ion Proton
data set, paired Vuong’s non-nested hypothesis tests
were conducted on the 4 candidate distributions, with
details summarized in Additional file 5. The test conclu-
sions remained the same except for the NB (model 1)
and ZIP (model 2) comparison, where the BIC-corrected
Vuong z-statistic is −0.47 resulting in p value = 0.318.
Therefore the goodness-of-fit for these two distributions
on MiSeq dataset are not significantly different.
Despite similar statistical modeling schema can be
readily generalized to Illumina MiSeq data set, Illumina
MiSeq and Ion Proton sequencers differ significantly in
terms of sequencing chemistry. The former is based on
sequencing-by-synthesis (SBS) that relies on high-
resolution optic systems, whereas the latter is based on
Ion semiconductor sequencing where no modified nu-
cleotides or optics are required. The differences in se-
quencing mechanisms make Ion Proton sequencers run
faster but are prone to homopolymer related errors.
Comparing the NB GLM regression coefficients on both
datasets (Additional file 6), homopolymer related fea-
tures significant in Ion Proton data set regression are ei-
ther insignificant (hmer_len, hmer_dist) or show
opposite effect (hmer_op, hmer_den) on the error rate.
The same trend was also observed in ZIP and ZINB
models comparing Ion Proton with Illumina MiSeq
(Additional files 7, 8, 9 and 10).
To evaluate whether the differences in GLM coeffi-
cients affect the performance profiles on various allele
frequencies, we applied the 4 GLM models trained on
CAL_A to the other 3 calibration datasets and con-
ducted the recall, precision and F1 score analyses by al-
lele frequency on the combined dataset. As shown in
Fig. 5, similar to the Ion Proton data set, SNVs of lower
allele frequencies are more difficult to identify. However,
when comparing the performances of ZIP with NB GLM
on 0.5 % ~ 1 % allele frequency, different from Ion Pro-
ton dataset, NB demonstrated a much higher F1 score
compared with ZIP. A closer look at the performance
profiles shows the noticeable drop in recall comparing
NB with ZIP in Ion Proton is absent in MiSeq data.
Examination on the benchmark SNVs missed by NB but
Fig. 4 Performance by allele frequency summary on Ion Proton testing benchmark
Fig. 5 Performance by allele frequency summary on Illumina MiSeq testing benchmark
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recovered by ZIP showed lower depth for the missed
ones. While the absent of recall drop in MiSeq is due to
its relatively even depth contrast to the Ion Proton data-
set (Fig. 2). For SNVs with > 1 % allele frequency, the F1
scores are all greater than 0.9 and clustered together for
all distributions.
Comparing with the results from UDT-Seq [15], which
reported approximately 90 % recall and >95 % precision
(no specific number was given, the precision was in-
ferred by the precision for the other data UDT-Seq
tested - Illumina GAII benchmark data at 1500x depth),
ZINB GLM demonstrates higher overall recall (95.1 %)
and high precision (93.4 %).
Discussion
The PSEM model aims to predict the position specific
error rates associated with various genomic sequence
contexts, under which the specific sequencing technol-
ogy is prone to error. Based on publications evaluating
features associated with sequencing errors and experi-
ences from our previous effort, 9 types of significant fea-
tures are considered. With the features fixed, using
GLM, we evaluated the appropriateness of distributions
with different mean – variance relationships and the
ability to consider zero-inflation. Consistent with the
computational tool EdgeR [23] for RNA-Seq data, we
found the ability to model over-dispersion by NB distri-
bution necessary for DNA-Seq data as well. Additionally,
for DNA-Seq erroneous read counts modeling, zero-
inflation is also a key factor for accurate prediction and
inference. The much-elevated F1 score for 0.5 % allele
frequency SNVs as well as the highest overall perform-
ance by ZINB GLM highlighted the importance of
choosing suitable statistical models. Moreover, compar-
ing with VarScan2, which conducts the Fisher’s exact test
for each targeted location on paired normal-tumor se-
quencing data, the significance of applying the correct
reference error model is exemplified by higher recalls as
well as precisions for 0.5 % and 1 % frequency SNVs. In
theory, for low frequency SNV loci, VarScan2 treated the
sequencing reads with non-reference bases from normal
as the background error, which is essentially point esti-
mation based on one location. Whereas PSEM collect-
ively considers all loci with similar context features and
thus is able to generate more accurate error estimation.
The evaluation of PSEM modeling on Illumina MiSeq
dataset and the performance comparison with Ion Pro-
ton dataset show the generality of the PSEM framework
as well as its adaptiveness to different technologies.
Moreover, except for the established importance of
choosing appropriate statistical model, the sequencing
depth evenness is also an important factor affecting low-
frequency SNVs calling performances.
The current GLM-based PSEM framework only con-
siders 9 types of genome sequence context features. To
further improve the performances, more informative
features associated with sequencing errors should be in-
cluded and tested. In addition, from the modeling as-
pect, exploration of the potential to further increase the
performances by applying more sophisticated computa-
tional models are desired. To better understand its
generalizability and adaptiveness, tests on other se-
quencing technologies, such us SOLiD and Complete
Genomics, are necessary. Besides, since the capture
assay for the two benchmarks is amplicon-based,
hybridization-based approach should be tested to com-
pare the performance profiles.
Differentiating low frequency SNVs from sequencing
artifacts is the key for identifying SNVs at frequencies
close to sequencing error rates. Our PSEM approach
tried to push the limit toward the sequencing error rates.
Based on the analyses on benchmarks from standard se-
quencing protocols and the given sequencing depth, we
speculate the detection limit is around 0.5 % on the re-
gions covering all exons of hundred of genes, with a
total size up to millions of bases. However, with high ac-
curacy sequencing protocols, such as duplex sequencing
[24] and ultra-deep target enrichment assay [25], the re-
searchers reported identification of SNVs around 0.1 %
on a single gene scale. Despite the promising results,
more efforts to make such protocols applicable on larger
regions are required for broader applications.
Conclusion
Our method enables sensitive detection of low-
frequency single nucleotide variants across different se-
quencing platforms down to 0.5 % frequency. Thus will
facilitate research and clinical applications such as
pooled sequencing, cancer early detection, prognostic




For position specific error model training, we used the
invariant loci from training benchmark. Genomic se-
quence context features were extracted for each locus
and then fed to the generalized linear models using 4
different distributions. Then testing benchmark paired
tumor and normal sequencing data went through the
PSEM and the candidate SNVs were derived. Additional
file 11 provides a diagram illustrating this procedure. In
the following method section, we first introduced the
benchmark datasets from both Ion Proton and Illumina
MiSeq. Then we described the application of generalized
linear models for PSEM. Last, we described the perform-
ance evaluation metrics.
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Benchmark dataset
Both Ion Proton and Illumina MiSeq datasets were gen-
erated from amplicon-based targeted sequencing.
The targeted region for Ion Proton datasets included
all exons of 409 known cancer-related genes, totaling
about 1.7 million bases covered by about 16,000 ampli-
con primer pairs from Ion AmpliSeq™ Comprehensive
Cancer Panel. The training benchmark is the DNA se-
quencing data of NA11993. The testing benchmark
mimic the paired normal-tumor design, where the nor-
mal sample is the DNA sequencing data of NA12878
while tumor sample is a mixture of 17 individuals from
1000 Genomics Project plus NA12878. The mixing per-
centage assignment is listed in Additional file 2. The se-
quencing data were aligned with TMAP from Torrent
Suite software. Reads with mapping quality less than 40
were filtered out.
The length of targeted regions for Illumina MiSeq
datasets is 23.2 kb, covered by 158 amplicons. The
design details can be found in the paper [15] and
Additional file 3. The raw reads were downloaded
from NCBI Short Read Archive (SRP009487.1) and
processed as the paper described. Reads with mapping
quality less than 30 were filtered out.
Generalized linear models
The details of the 9 genomic sequence contexts consid-
ered in GLM were summarized in Additional file 4.
Briefly, general contexts including substitution types, im-
mediate upstream and downstream bases, GC content,
and homopolymer related features: whether the locus is
within a homopolymer, the closest homopolymer length,
the distance to the closest homopolymer, the local ho-
mopolymer base percentages and whether the alternative
base is the same as the immediate upstream or down-
stream base are considered. These 9 features are the co-
variates included in the GLMs.
The Poisson GLM for erroneous sequencing read
counts with log link function is expressed in eq. (1),
where Ns,b,l is the observed number of erroneous reads
for strand s (forward or reverse) with alternative base b
(three possible values other than the reference) at loca-
tion l, λs,b,l represents the expected mean for Ns,b,l, cs,b,l
is the vector of genomic sequence context covariates,
and β is the vector of fitted coefficients. The sequencing
depth for strand s at location l is treated as the offset.
log λs;b;l
  ¼ log E Ns;b;ljcs;b;l  
¼ log ds;l
 þ β0cs;b;l ð1Þ
The negative binomial distribution GLM with log link
function can be expressed in eq. (2), where μs,b,l repre-
sents the expected mean for Ns,b,l and θ is the dispersion
parameter (the shape parameter of the gamma mixing
distribution). The mean E(Ns,b,l) = μs,b,l and variance
VAR(Ns,b,l) = μs,b,l + θμs,b,l




¼ log E Ns;b;ljcs;b;l
  
¼ log ds;l
 þ β0cs;b;l ð2Þ
The zero-inflated Poisson distribution can be written as:
P Ns;b;l ¼ ns;b;ljπs;b;l; λs;b;l; θ
 




if ns;b;l ¼ 0
1−πs;b;l
 
Pois λs;b;l; ; ns;b;l
 
if ns;b;l > 0

ð3Þ
Parameters of the zero-inflated Poisson distribution
(3) can be estimated by generalized linear model as
shown in (4), where zs,b,l is the vector of genomic se-
quence context covariates for the zero part, and γ is the





¼ γ 0zs;b;l ð4Þ
log λs;b;l
  ¼ β0cs;b;l
The zero-inflated negative binomial distribution can
be written as:





NB μs;b;l; θ; 0
 
if ns;b;l ¼ 0
1−πs;b;l
 
NB μs;b;l; θ; ; ns;b;l
 




Parameters of the zero-inflated negative binomial dis-
tribution (5) can be estimated by generalized linear









A location with a certain alternative base is called as a
candidate SNV if the numbers of reads from both strands
are significantly greater than the predicted error rates.
The p values were corrected using Benjamini–Hochberg
procedure. The corrected p value cut-off is 0.01.
Performance evaluation measurements
Precision, recall and F1 score are defined below.
precision ¼ number of recovered benchmark SNVs
number of predicted SNVs
recall ¼ number of recovered benchmark SNVs
expected number of benchmark SNVs
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F1 ¼ 2  precision  recall
precisionþ recall
For Ion Proton dataset, loci with at least 5 reads sup-
porting alternative base are included in the evaluation.
For Illumina MiSeq dataset, filter 2 used by UDT-Seq
was applied which requires > = 0.2 % frequency for alter-
native bases. However, the other filters were not used.
We relied on the PSEM framework to properly address
sequencing problems, for example, uneven depth and
local sequence context induced errors.
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